These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28902356)

  • 1. miR-378 functions as an onco-miRNA by targeting the ST7L/Wnt/β-catenin pathway in cervical cancer.
    Li S; Yang F; Wang M; Cao W; Yang Z
    Int J Mol Med; 2017 Oct; 40(4):1047-1056. PubMed ID: 28902356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling.
    Chen L; Zhang A; Li Y; Zhang K; Han L; Du W; Yan W; Li R; Wang Y; Wang K; Pu P; Jiang T; Jiang C; Kang C
    Cancer Lett; 2013 Feb; 329(2):174-80. PubMed ID: 23142218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-23a promotes IKKα expression but suppresses ST7L expression to contribute to the malignancy of epithelial ovarian cancer cells.
    Yang Z; Wang XL; Bai R; Liu WY; Li X; Liu M; Tang H
    Br J Cancer; 2016 Sep; 115(6):731-40. PubMed ID: 27537390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer.
    Bai D; Sun H; Wang X; Lou H; Zhang J; Wang X; Jiang L
    Med Sci Monit; 2017 Oct; 23():4885-4894. PubMed ID: 29023429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-577 suppresses cell proliferation and epithelial-mesenchymal transition by regulating the WNT2B mediated Wnt/β-catenin pathway in non-small cell lung cancer.
    Wang B; Sun L; Li J; Jiang R
    Mol Med Rep; 2018 Sep; 18(3):2753-2761. PubMed ID: 30015869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GRSF1-mediated MIR-G-1 promotes malignant behavior and nuclear autophagy by directly upregulating TMED5 and LMNB1 in cervical cancer cells.
    Yang Z; Sun Q; Guo J; Wang S; Song G; Liu W; Liu M; Tang H
    Autophagy; 2019 Apr; 15(4):668-685. PubMed ID: 30394198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1.
    Li Z; Wang H; Wang Z; Cai H
    Tumour Biol; 2016 May; 37(5):6457-63. PubMed ID: 26631043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-139-3p induces cell apoptosis and inhibits metastasis of cervical cancer by targeting NOB1.
    Huang P; Xi J; Liu S
    Biomed Pharmacother; 2016 Oct; 83():850-856. PubMed ID: 27505862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
    Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
    Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-331-3p Links to Drug Resistance of Pancreatic Cancer Cells by Activating WNT/β-Catenin Signal via ST7L.
    Zhan T; Chen X; Tian X; Han Z; Liu M; Zou Y; Huang S; Chen A; Cheng X; Deng J; Tan J; Huang X
    Technol Cancer Res Treat; 2020; 19():1533033820945801. PubMed ID: 32924881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
    Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
    Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM-2.
    Li GC; Cao XY; Li YN; Qiu YY; Li YN; Liu XJ; Sun XX
    J Cell Physiol; 2018 Sep; 233(9):7379-7390. PubMed ID: 29575013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
    Hsu W; Liu L; Chen X; Zhang Y; Zhu W
    Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
    Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
    BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
    Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of hsa-miR-103a and hsa-miR-1827 and hsa-miR-137 as new regulators of Wnt signaling pathway and their relation to colorectal carcinoma.
    Fasihi A; M Soltani B; Atashi A; Nasiri S
    J Cell Biochem; 2018 Jul; 119(7):5104-5117. PubMed ID: 28817181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-638 inhibits cervical cancer metastasis through Wnt/β-catenin signaling pathway and correlates with prognosis of cervical cancer patients.
    Wei H; Zhang JJ; Tang QL
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5587-5593. PubMed ID: 29271990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.
    Fujii T; Shimada K; Asano A; Tatsumi Y; Yamaguchi N; Yamazaki M; Konishi N
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.